You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thiazolidinediones

Showing 1 - 25 of 204
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Baltimore (Pioglitazone)

Completed
Has Results
  • Type 2 Diabetes
  • Baltimore, Maryland
    University of Maryland School of Medicine
Apr 27, 2021

Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),

Completed
  • Type 2 Diabetes Mellitus
  • Liraglutide
  • Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
  • Chongqing, Chongqing, China
    The third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022

Diabetes, Type 2 Trial (MK0653, ezetimibe / Duration of Treatment: 30 Weeks, Comparator : ezetimibe (+) simvastatin / Duration

Completed
  • Diabetes Mellitus, Type 2
  • MK0653, ezetimibe / Duration of Treatment: 30 Weeks
  • Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weeks
  • (no location specified)
Feb 7, 2022

Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular Trial in León (Dapagliflozin 10mg Tab, Statins (Cardiovascular

Recruiting
  • Stroke, Ischemic
  • +3 more
  • Dapagliflozin 10mg Tab
  • +3 more
  • León, Guanajuato, Mexico
    Hospital General de Zona IMSS 21
Oct 3, 2022

NAFLD - Nonalcoholic Fatty Liver Disease, Type2 Diabetes Trial in Seoul (Pioglitazone, Empagliflozin, Combination of

Unknown status
  • NAFLD - Nonalcoholic Fatty Liver Disease
  • Type2 Diabetes
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine, Department of Internal Me
Oct 15, 2020

Chronic Kidney Diseases Trial in Arlington, Dallas (Pioglitazone, Placebo)

Recruiting
  • Chronic Kidney Diseases
  • Arlington, Texas
  • +1 more
May 24, 2022

NAFLD Trial in Cairo (Control Test)

Completed
  • NAFLD
  • Control Test
  • Cairo, Egypt
    Ain Shams University
Oct 5, 2023

Diabetes, Type 2 Trial in Shanghai (Strengthen self-monitoring of blood glucose)

Completed
  • Diabetes Mellitus, Type 2
  • Strengthen self-monitoring of blood glucose
  • Shanghai, China
    Ruijin Hospital North
Sep 20, 2021

Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)

Recruiting
  • Acute Ischemic Stroke
  • Basilar Artery Occlusion
  • Best medical management
  • Endovascular treatment
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 20, 2023

Type 2 Diabetes Trial (Diabetes Medicines, Dapagliflozin)

Unknown status
  • Type 2 Diabetes Mellitus
  • (no location specified)
Mar 11, 2019

Polypharmacy Trial (Clinical decision support (CDS)-Commitment nudge, Clinician education, Clinical decision support

Not yet recruiting
  • Polypharmacy
  • Clinical decision support (CDS)-Commitment nudge
  • +2 more
  • (no location specified)
Dec 9, 2022

Non-Alcoholic Fatty Liver Disease Trial in Toronto

Recruiting
  • Non-Alcoholic Fatty Liver Disease
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Nov 1, 2022

    Uric Acid Kidney Stone Disease Trial in Dallas (Pioglitazone, Placebo)

    Recruiting
    • Uric Acid Kidney Stone Disease
    • Dallas, Texas
      UT Southwestern Medical Center - Center for Mineral Metabolism
    Dec 20, 2021

    Type 2 Diabetes Trial in Seongnam (Pioglitazone, Lobeglitazone)

    Recruiting
    • Type 2 Diabetes
    • Seongnam, Gyeonggi, Korea, Republic of
      Seoul National University Bundang Hospital
    Mar 29, 2021

    SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Type

    Terminated
    • Type2 Diabetes
    • Cognitive Impairment
    • MOCA cognitive evaluation test
    • +3 more
    • Istanbul, Turkey
      Istanbul Medeniyet University Goztepe Research and Training Hosp
    Apr 16, 2022

    Irisin And Diabetic Nephropathy

    Not yet recruiting
    • Irisin
    • Laboratory tests
    • +5 more
    • (no location specified)
    Nov 20, 2021

    Diabetes, Type 2 Trial in Catanzaro (Metformin / alogliptin Oral Product, Metformin / Pioglitazone Pill, triple therapy)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Metformin / alogliptin Oral Product
    • +2 more
    • Catanzaro, Italy
      ASP Catanzaro
    Sep 11, 2020

    Diabetes, Type 2 Trial in Jinan (behavioral, drug, other)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Lifestyle therapy
    • +3 more
    • Jinan, Shandong, China
    • +1 more
    Jul 5, 2021

    End-stage Renal Disease Trial in Hong Kong (Pioglitazone, comparator)

    Completed
    • End-stage Renal Disease
    • Hong Kong, Hong Kong
      Queen Mary Hospital, Tung Wah Hospital
    Oct 1, 2021

    Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus

    Completed
    • Type2 Diabetes
    • Duvie(Lobeglitazone) tab 0.5mg
    • Seoul, Korea, Republic of
      Division of Endocrinology and Metabolism, Department of Internal
    Sep 12, 2021

    Type 2 Diabetes Trial in Turkey (INSULIN GLARGINE (U300), metformin, sulfonylurea)

    Completed
    • Type 2 Diabetes Mellitus
    • INSULIN GLARGINE (U300)
    • +8 more
    • Turkey, Turkey
      (unnamed)
    Jan 10, 2019

    Healthy Trial in Boston (High calorie diet, Fasting)

    Completed
    • Healthy
    • High calorie diet
    • Fasting
    • Boston, Massachusetts
      Massachusettes General Hospital
    Feb 26, 2021

    Polycystic Ovary Syndrome, Insulin Resistance Trial in Guangzhou (true acupuncture, sham acupuncture, metformin)

    Completed
    • Polycystic Ovary Syndrome
    • Insulin Resistance
    • true acupuncture
    • +3 more
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Guangzhou Medical University
    Mar 17, 2022

    Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)

    Completed
    • Type 2 Diabetes
    • Sitagliptin - DPP4i
    • +2 more
    • Exeter, United Kingdom
      Exeter Clinical Research Facility
    Mar 30, 2021

    Ibuprofen and Other Medicines on Severity of Coronavirus Disease

    Withdrawn
    • Coronavirus Infection
    • Questionnaire
    • (no location specified)
    Feb 22, 2021